FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TREMELIMUMAB
异名/同义词CP-675,206
CP-675206
IMJUDO
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULFIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
PF-06753388
TICILIMUMAB
TREMELIMUMAB
TREMELIMUMAB (GENETICAL RECOMBINATION)
TREMELIMUMAB (GENETICAL RECOMBINATION) [JAN]
TREMELIMUMAB [INN]
TREMELIMUMAB [JAN]
TREMELIMUMAB [USAN]
TREMELIMUMAB [WHO-DD]
TREMELIMUMAB-ACTL
CAS登记号745013-59-6
物质唯一标识(Unique Ingredient Identifier)QEN1X95CIX
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System